Abstract:As deaths from acute myocardial infarction have declined dramatically over the past several decades, more and more patients survive with chronic myocardial ischemia.1,2 Hearts of most patients who survive acute myocardial infarction undergo remodeling. Hearts of most patients with sustained hypertension, another common cardiovascular disease, also show some degree of remodeling. The heart consists of 3 primary cell types: cardiomyocytes, fibroblasts, and endothelial cells. Myocytes occupy 75% of cardiac mass, generate the electric impulses, and induce cardiac contraction. Fibroblasts are primarily responsible for the maintenance of extracellular matrix (ECM) that is composed of collagens, fibronectins, elastins, fibrillins, and several other proteins. The capillary microcirculation network composed primarily of endothelial cells that serves the contractile assembly.3 In state of health, renin–angiotensin–aldosterone system is thought to be responsible for sustenance of cardiomyocyte, fibroblast, and endothelial cell biology. However, renin–angiotensin–aldosterone system activation leads to profound changes in cell biology during sustained hypoxia. Cardiomyocytes in the regions adjacent to ischemic area become large to maintain cardiac contraction. Fibroblasts around the cardiomyocytes begin to grow and differentiate into myofibroblasts to compensate for low-cardiac output. This process of cardiomyocyte hypertrophy and cardiac fibroblast growth is commonly known as cardiac remodeling.4–6 Release of large amounts of reactive oxygen species in the ischemic myocardium and the associated inflammatory response are thought to be mechanistic contributors to cardiac remodeling. Local activation of renin–angiotensin–aldosterone system contributes to further reactive oxygen species generation and release of transforming growth factor-β (TGF-β); the latter plays a central role in fibroblast transformation into myofibroblasts and subsequent activation of matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and synthesis of collagens.7 MMPs and TIMPs mediate the balance between formation of collagens and their degradation, and their abnormal expression promotes secretion of large amounts of collagens by rapidly …

Mechanoregulation of Cardiac Myofibroblast Differentiation: Implications for Cardiac Fibrosis and Therapy

Fibroblast Proliferation Alters Cardiac Excitation Conduction and Contraction: a Computational Study.

Full title: Mechano-regulation of Cardiac Myofibroblast Differentiation: Implications

Mechanical control of cardiac myofibroblasts

Cardiac fibroblasts and mechanosensation in heart development, health and disease

Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Myofibroblasts and Fibrosis

Extracellular matrix remodeling and cardiac fibrosis

Construction of cardiac fibrosis for biomedical research

Cellular Modulation by the Mechanical Cues from Biomaterials for Tissue Engineering.

Cardiac Fibrosis: New Insights into the Pathogenesis

Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis

3D matrix stiffness modulation unveils cardiac fibroblast phenotypic switching

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease

Epigenetic Regulation of Fibroblasts and Crosstalk between Cardiomyocytes and Non-Myocyte Cells in Cardiac Fibrosis

Role of Cardiac Fibroblasts in Cardiac Injury and Repair

Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation Via Angiotensin II Type 1 Receptor and Smad7.

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling